Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. Bone Marrow Transplant 2016 Dec;51(12):1599-1601
Date
08/16/2016Pubmed ID
27526284Pubmed Central ID
PMC5143194DOI
10.1038/bmt.2016.215Scopus ID
2-s2.0-84982085195 (requires institutional sign-in at Scopus site) 38 CitationsAuthor List
O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise DAuthors
Mary Eapen MBBS, DCh, MRCPI, MS Professor in the Medicine department at Medical College of WisconsinMary M. Horowitz MD, MS Professor in the Medicine department at Medical College of Wisconsin
Brent R. Logan PhD Director, Professor in the Institute for Health and Equity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdolescentAdult
Age Factors
Aged
Bone Marrow Transplantation
Clinical Trials, Phase II as Topic
Cohort Studies
Female
Hematopoietic Stem Cell Transplantation
Humans
Leukemia
Male
Matched-Pair Analysis
Middle Aged
Multicenter Studies as Topic
Myelodysplastic Syndromes
Peripheral Blood Stem Cell Transplantation
Stem Cells
Time Factors
Transplantation Conditioning
Transplantation, Homologous
Treatment Outcome